Women with atrial fibrillation face a higher risk of ischemic stroke than men
Women with atrial fibrillation who are not on anticoagulant therapy have a higher rate of ischemic stroke and face a higher absolute risk for stroke than do men with the condition, according to a joint study by researchers at the University of California, San Francisco, Massachusetts General Hospital, the Division of Research at Kaiser Permanente and Boston University School of Medicine.
Using a sample of 13,559 patients with atrial fibrillation, or rapid irregular contractions of the heart, researchers compared the rates of ischemic stroke between men and women and examined the efficacy and complications associated with a common blood thinner, Warfarin. Their findings are being reported in the September 20 issue of Circulation.
Warfarin is well known to be effective in reducing the risk of stroke in persons with atrial fibrillation; however prior studies have provided conflicting evidence about whether women with atrial fibrillation have a higher risk for stroke than men when not taking blood thinners. "The research from this study clearly shows that gender plays a role in ischemic stroke risk and occurrence," said lead author Margaret Fang, MD, MPH, assistant adjunct professor of medicine, and hospitalist at UCSF Medical Center.
The higher incidence of stroke in women not taking Warfarin therapy occurred among women in all stroke-risk-factor categories, including those with prior stroke, hypertension, congestive heart failure, coronary artery disease and diabetes. Because of the significant differences in the rate of stroke between men and women, the study indicates that being a woman is an independent risk factor for stroke and should be considered when choosing treatment options for women with atrial fibrillation.
According to the researchers, atrial fibrillation is the most common cardiac arrhythmia, and a major risk factor for both ischemic stroke and peripheral embolism, an obstruction of the blood supply to an organ. Anticoagulation therapies, such as Warfarin, are well known to substantially reduce the risk of atrial fibrillation-related stroke and embolism, but also have been shown to increase the risk for hemorrhage. "Because of this increased hemorrhage risk, physicians are sometimes hesitant to prescribe the drug, and some studies have shown that women are less likely to receive warfarin therapy than men," Fang said. "However, we found that women in our study did not suffer bleeding complications related to Warfarin more often than men who were using the therapy."
Furthermore, data showed that women may actually benefit more from Warfarin because of their higher baseline risk for stroke. "Women with atrial fibrillation, particularly those with other risk factors for stroke, should be especially encouraged to take Warfarin," Fang added.
Vanessa deGier | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...